NeoGenomics Inc (NEO)
13.69
-0.16
(-1.16%)
USD |
NASDAQ |
Apr 17, 16:00
13.69
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Cash from Investing (Quarterly): 17.20M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.20M |
| September 30, 2023 | 20.82M |
| June 30, 2023 | 14.95M |
| March 31, 2023 | 23.74M |
| December 31, 2022 | -1.063M |
| September 30, 2022 | -4.198M |
| June 30, 2022 | -6.274M |
| March 31, 2022 | 12.05M |
| December 31, 2021 | -9.583M |
| September 30, 2021 | -14.69M |
| June 30, 2021 | -453.41M |
| March 31, 2021 | -154.69M |
| December 31, 2020 | -28.85M |
| September 30, 2020 | -70.72M |
| June 30, 2020 | -18.16M |
| March 31, 2020 | -41.71M |
| December 31, 2019 | -6.076M |
| September 30, 2019 | -7.316M |
| June 30, 2019 | -3.042M |
| March 31, 2019 | -3.196M |
| December 31, 2018 | -128.60M |
| September 30, 2018 | -2.148M |
| June 30, 2018 | -4.277M |
| March 31, 2018 | -4.666M |
| December 31, 2017 | -3.523M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.303M |
| June 30, 2017 | -4.857M |
| March 31, 2017 | -3.007M |
| December 31, 2016 | -1.173M |
| September 30, 2016 | -1.903M |
| June 30, 2016 | -2.424M |
| March 31, 2016 | -1.001M |
| December 31, 2015 | -73.47M |
| September 30, 2015 | -0.502M |
| June 30, 2015 | -0.338M |
| March 31, 2015 | -0.842M |
| December 31, 2014 | -1.054M |
| September 30, 2014 | -6.582M |
| June 30, 2014 | -1.083M |
| March 31, 2014 | -0.883M |
| December 31, 2013 | -0.525M |
| September 30, 2013 | -0.878M |
| June 30, 2013 | -0.369M |
| March 31, 2013 | -0.239M |
| December 31, 2012 | -0.352M |
| September 30, 2012 | -1.25M |
| June 30, 2012 | -0.736M |
| March 31, 2012 | -1.314M |
| December 31, 2011 | -0.559M |
| September 30, 2011 | -0.213M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-453.41M
Minimum
Jun 2021
23.74M
Maximum
Mar 2023
-38.47M
Average
-6.274M
Median
Jun 2022
Cash from Investing (Quarterly) Benchmarks
| Teladoc Health Inc | -36.51M |
| Halozyme Therapeutics Inc | -8.291M |
| Verastem Inc | 12.44M |
| Ocugen Inc | -3.365M |
| Gritstone Bio Inc | 38.30M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 17.78M |
| Cash from Financing (Quarterly) | 1.27M |
| Free Cash Flow | -30.70M |
| Free Cash Flow Per Share (Quarterly) | 0.0852 |
| Free Cash Flow to Equity (Quarterly) | 10.00M |
| Free Cash Flow to Firm (Quarterly) | 10.73M |
| Free Cash Flow Yield | -1.79% |